Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colon | 4 | 2020 | 509 | 1.200 |
Why?
|
| Pluripotent Stem Cells | 2 | 2022 | 32 | 0.990 |
Why?
|
| Exosomes | 2 | 2023 | 53 | 0.950 |
Why?
|
| Human Embryonic Stem Cells | 2 | 2019 | 5 | 0.810 |
Why?
|
| Tissue Engineering | 3 | 2019 | 185 | 0.790 |
Why?
|
| Cell-Derived Microparticles | 1 | 2021 | 12 | 0.780 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 42 | 0.730 |
Why?
|
| Organoids | 4 | 2020 | 62 | 0.670 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 2357 | 0.660 |
Why?
|
| Neuroendocrine Cells | 1 | 2019 | 4 | 0.660 |
Why?
|
| Bioartificial Organs | 1 | 2019 | 2 | 0.660 |
Why?
|
| Immunotherapy | 1 | 2024 | 678 | 0.660 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 25 | 0.640 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 23 | 0.620 |
Why?
|
| Receptors, CCR | 2 | 2015 | 4 | 0.620 |
Why?
|
| Coculture Techniques | 1 | 2018 | 173 | 0.610 |
Why?
|
| Colorectal Neoplasms | 3 | 2017 | 981 | 0.610 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 111 | 0.600 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 111 | 0.580 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2017 | 41 | 0.580 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 244 | 0.580 |
Why?
|
| Lung | 6 | 2022 | 1259 | 0.520 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 1116 | 0.510 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2015 | 26 | 0.510 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 573 | 0.490 |
Why?
|
| Liver | 2 | 2020 | 1206 | 0.470 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 805 | 0.440 |
Why?
|
| Stem Cells | 3 | 2021 | 372 | 0.430 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 540 | 0.420 |
Why?
|
| Chemokines, CC | 1 | 2012 | 36 | 0.420 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1429 | 0.380 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2363 | 0.330 |
Why?
|
| Neoplasms | 2 | 2021 | 3037 | 0.310 |
Why?
|
| Receptors, Notch | 3 | 2019 | 123 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1265 | 0.270 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 195 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 470 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2015 | 3376 | 0.250 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1194 | 0.250 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 31 | 0.240 |
Why?
|
| Humans | 17 | 2024 | 89222 | 0.230 |
Why?
|
| Animals | 10 | 2024 | 27338 | 0.230 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2880 | 0.200 |
Why?
|
| Adrenoleukodystrophy | 1 | 2021 | 4 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 116 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2016 | 551 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 617 | 0.190 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 146 | 0.190 |
Why?
|
| Tropism | 1 | 2020 | 4 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 105 | 0.180 |
Why?
|
| Organogenesis | 2 | 2020 | 50 | 0.180 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 2553 | 0.170 |
Why?
|
| Mice | 7 | 2023 | 11743 | 0.170 |
Why?
|
| Hypoxia | 1 | 2024 | 651 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 497 | 0.170 |
Why?
|
| Macrophages | 1 | 2022 | 571 | 0.160 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 67 | 0.160 |
Why?
|
| Urea | 1 | 2018 | 59 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 48 | 0.160 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 123 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 511 | 0.150 |
Why?
|
| Albumins | 1 | 2018 | 129 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 164 | 0.150 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2017 | 39 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1057 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2020 | 477 | 0.140 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 116 | 0.140 |
Why?
|
| Cell-Free System | 1 | 2016 | 51 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 37 | 0.140 |
Why?
|
| Asymmetric Cell Division | 1 | 2016 | 3 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 414 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2019 | 500 | 0.130 |
Why?
|
| Blastocyst | 1 | 2015 | 35 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 246 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 117 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1764 | 0.120 |
Why?
|
| Cell Division | 1 | 2016 | 696 | 0.120 |
Why?
|
| Biomimetics | 1 | 2014 | 31 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2016 | 211 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 181 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 161 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1650 | 0.120 |
Why?
|
| Models, Biological | 1 | 2020 | 1765 | 0.110 |
Why?
|
| Transcription Factor HES-1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Mutation | 2 | 2021 | 4141 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2012 | 73 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2012 | 261 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 397 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 170 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 1108 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 576 | 0.090 |
Why?
|
| Virus Internalization | 2 | 2020 | 39 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 971 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 308 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1216 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 556 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1521 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1975 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 144 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 26 | 0.050 |
Why?
|
| Viral Tropism | 1 | 2020 | 4 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 31 | 0.050 |
Why?
|
| Rabbits | 1 | 2021 | 638 | 0.050 |
Why?
|
| Heterografts | 1 | 2020 | 102 | 0.050 |
Why?
|
| Autopsy | 1 | 2020 | 122 | 0.040 |
Why?
|
| Drug Approval | 1 | 2020 | 66 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 135 | 0.040 |
Why?
|
| Immune System | 1 | 2021 | 97 | 0.040 |
Why?
|
| Species Specificity | 1 | 2021 | 684 | 0.040 |
Why?
|
| Child | 2 | 2021 | 7158 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 119 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 996 | 0.040 |
Why?
|
| Cognition | 1 | 2023 | 580 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 246 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2017 | 7 | 0.040 |
Why?
|
| Gentamicins | 1 | 2017 | 20 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2017 | 20 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 31 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 78 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 1183 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 323 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1990 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 97 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 277 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 282 | 0.030 |
Why?
|
| Sirolimus | 1 | 2017 | 170 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 60 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1838 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 794 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2495 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 178 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 691 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 247 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 2439 | 0.030 |
Why?
|
| Neurons | 1 | 2023 | 1580 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 2481 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 291 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 344 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 232 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 3152 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3724 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3779 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1799 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 956 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2338 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 699 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 2327 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 507 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3027 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5490 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9247 | 0.020 |
Why?
|
| Male | 2 | 2021 | 42347 | 0.020 |
Why?
|
| United States | 1 | 2020 | 6975 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 9034 | 0.020 |
Why?
|
| Female | 2 | 2021 | 46118 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 19128 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 25929 | 0.010 |
Why?
|